INCURON

developing

Incuron, LLC is developing an innovative pipeline of drugs to treat oncology for the global markets.

About

Incuron, LLC is a Russian Federation based joint venture founded in January 2010 between Russian Closed Mutual Venture Fund "Bioprocess Capital Ventures", and Cleveland BioLabs. Incuron, LLC is developing an innovative pipeline of drugs to treat oncology for the global markets.

Pipeline

CBL0137
CBL0102
CBL0102+Erlotinib

Our News

Incuron, LLC Announces

Incuron Announces Notice of Allowance from FDA to Commence Clinical Trials of CBL0137. (далее…)

Cell Reports Publication

Cell Reports Publication Elucidates Role of FACT as Accelerator of Tumor Transformation and Potential Marker and Target of Aggressive Cancers…

Newsletter Form

Display a small newsletter subscription form. Integrates with services such as MailChimp and ConstantContact.

Contact

Contact Info

info@incuron.com
73 High Street, Buffalo, NY 14203
Telephone/Fax: (716) 588-0007
Incuron LLC